Most recently, a pro-inflammatory role for GPR4 has been proposed in COVID-19 [48], where GPR4 gene expression was found to be upregulated in COVID-19 patients’ lung and colon samples by 2.3-fold and 3.9-fold, respectively [47,48]. The gene discussed is GPR4; the disease is COVID-19.